Dividend & Audited Results- Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 19, 2025 inter alia, to consider, approve and take on record the Audited Financial Results of the Company for the quarter and Financial Year ended March 31, 2025 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2025.

Pasupati Acrylon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve the Audited Financial Results for the quarter and year ended 31st March 2025

Sundrop Brands Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the Financial Year ended 31st March 2025

IG Petrochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the year ended 31st March 2025 and recommend final dividend

Binani Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve Dear Sir/ Madam This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday 19th May 2025 to consider and transact the following businesses: 1. To approve Audited Financials (Standalone and Consolidated) along with Report of the Auditors for Quarter and Year ended 31st March 2025 pursuant to Regulation 33 of the Listing Obligation and Disclosure Requirement 2015. 2. Any other matter with the permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director.